Corporate Presentation – Proactive’s CEO Spotlight Investor Sessions (Melbourne & Sydney)

Managing director Dr Richard Lipscombe showcasing the company and PromarkerD, the world leading predictive diagnostic test for diabetic kidney disease, at Investor Briefings as part of Proactive’s CEO Spotlight Investor Session in Melbourne and Sydney.

Global leader in applying proteomics to MedTech

  • This field is for validation purposes and should be left unchanged.